当前位置： 阿仪网 > 生命科学 > 细胞分析 > 细胞培养装置 > 上海富衡生物科技有限公司 > 产品展示 > 细胞库 > 人源细胞 > SV40转染人成骨细胞hFOB1.19 (STR)FH0117
SV40转染人成骨细胞hFOB1.19 (STR)FH0117
价格：￥电议
品牌名称：富衡型号：FH0117 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：hFOB 1.19细胞系是通过将一种温度敏感型SV40大T抗原（ts-SV40）转染入正常人工流产胎儿（孕周约19周）的成骨细胞中构建而成的永生化细胞系。该细胞是一种非常重要且独特的人成骨细胞模型，在骨骼生物学研究领域应用广泛。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：645
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：630044
详细内容
| 产品名称 | SV40转染人成骨细胞；hFOB1.19 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | hFOB1.19 (STR) |
| 货号 | FH0117 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 3000.0 |
| 培养 | DMEM/F12+0.3mg/mlG418+10%FBS |
| 别称 | hFOB1.19; hFOB |
| 形态特征 | 上皮样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：33.5℃ |
| 传代方法 | 消化2-3分钟，1:2传代 |
| 组织来源 | 自然流产胎儿的四肢组织 |
| 细胞简介 | 该细胞系是在 0.6mg/ml G418 存在下，用温度敏感的表达载体 pUCSVisA58 和新霉素抗性表达载体 pSV2 - neo 转染自然流产的胎儿四肢组织建立的 |
| 特征特性 | 在0.6mg/ml新霉素G418存在下，用温度敏感的表达载体pUCSVisA58转染自然流产的胎儿四肢组织，建立了此细胞系。在许可温度33.5oC下细胞分裂很快，而在限制温度39.5oC下细胞极少分裂或不分裂。这些细胞具有分化为表达造骨细胞表型的成熟造骨细胞的能力。这些细胞提供了一个同质化的快速增殖模型系统，用于研究正常人造骨细胞的分化，造骨细胞生理和激素，生长因子，和对造骨细胞的功能及分化有影响的细胞因子。 |
| 培养基 | hFOB1.19完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| Prognostic value and immune infiltration of anoikis-related genes in osteosarcoma | 10.3389/fmed.2025.1669470 | 2025-11-06 | Frontiers in Medicine | 3.0 | Jianming Mo, Hening Li, Hui Wang, Xu Fang, Jie Ma, Kaiwei Chen |
| mir⁻⁷44-5p inhibits cell growth and angiogenesis in osteosarcoma by targeting NFIX | 10.1186/s13018-024-04947-x | 2024-08-17 | Journal of Orthopaedic Surgery and Research | 2.8 | Xie Lin, Li Wei, Li Yu |
| Momordin Ic Inhibits the Partially Malignant Phenotype of Osteosarcoma Cells by Inducing Apoptosis and Autophagy | 10.1177/1934578X241228966 | 2024-02-07 | Natural Product Communications | 1.5 | Ruiqing Xu, Rui Huang, Jiandang Shi, Dawei Chu, Pengyu Yang |
| Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients | 10.1016/j.intimp.2023.111364 | 2023-12-14 | INTERNATIONAL IMMUNOPHARMACOLOGY | 5.6 | Yunhua Lin, Haijun Tang, Hongcai Teng, Wenyu Feng, Feicui Li, Shangyu Liu, Yun Liu, Qingjun Wei |
| Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma | 10.1111/cas.15821 | 2023-05-07 | CANCER SCIENCE | 5.7 | Feicui Li, Haijun Tang, Xiaoting Luo, Xiangde Li, Kai Luo, Shangyu Liu, Jiming Liang, Shijie Liao, Chaoyi Zhong, Xinli Zhan, Qingjun Wei, Wenyu Feng, Yun Liu |
| A novel circular RNA circRBMS3 regulates proliferation and ｍmbedstasis of osteosarcoma by targeting miR-424-eIF4B/YRDC axis | 10.18632/aging.204567 | 2023-03-09 | Aging-US | 5.2 | Zhe Gong, Panyang Shen, Haitao Wang, Jinjin Zhu, Kaiyu Liang, Kefan Wang, Yunfeng Mi, Shuying Shen, Xiangqian Fang, Gang Liu |
| High GNG4 predicts adverse prognosis for osteosarcoma: Bioinｆormatics prediction and experimental verification | 10.3389/fonc.2023.991483 | 2023-02-10 | Frontiers in Oncology | 4.7 | Xiaohong Jiang, Fuxing Tang, Junlei Zhang, Mingwei He, Tianyu Xie, Haijun Tang, Jianhong Liu, Kai Luo, Shenglin Lu, Yun Liu, Jili Lu, Maolin He, Qingjun Wei |
| ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing | 10.2147/IJGM.S341879 | 2022-11-14 | International Journal of General Medicine | 2.145 | Zhaojie Qin, Kai Luo, Yun Liu, Shijie Liao, Juliang He, Mingwei He, Tianyu Xie, Xiaohong Jiang, Boxiang Li, Huijiang Liu, Qian Huang, Haijun Tang, Wenyu Feng, Xinli Zhan |
| TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells | 10.1007/s11033-022-07133-6 | 2022-01-15 | MOLECULAR BIOLOGY REPORTS | 2.742 | Yu De-Chen, Chen Xiang-Yi, Zhou Hai-Yu, Yu De-Quan, Yu Xiao-Lei, Hu Yi-Cun, Zhang Rui-Hao, Zhang Xiao-Bo, Zhang Kun, Lin Mao-Qiang, Gao Xi-Dan, Guo Tao-Wen |
| circCAMSAP1 promotes osteosarcoma progression and ｍmbedstasis by sponging miR-145-5p and regulating FLI1 expression | 10.1016/j.omtn.2020.12.013 | 2020-12-23 | Molecular Therapy-Nucleic Acids | 7.032 | Zizheng Chen, Wenbin Xu, Deguang Zhang, Junjie Chu, Shuying Shen, Yan Ma, Qingxin Wang, Gang Liu, Teng Yao, Yizhen Huang, Huali Ye, Jiying Wang, Jianjun Ma, Shunwu Fan |
| CircECE1 activates energy ｍmbedbolism in osteosarcoma by stabilizing c-Myc | 10.1186/s12943-020-01269-4 | 2020-10-26 | Molecular Cancer | 15.302 | Shen Shuying, Yao Teng, Xu Yining, Zhang Deguang, Fan Shunwu, Ma Jianjun |
| MicroRNA‑1236‑3p inhibits human osteosarcoma growth | 10.3892/ol.2020.12229 | 2020-10-15 | Oncology Letters | 2.311 | Jiarui Li, Junxin Chen, Zhijun Hu, Wenbin Xu |
| CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells | 10.1186/s12943-018-0917⁻⁷ | 2018-12-04 | Molecular Cancer | 7.776 | Liu Gang, Huang Kangmao, Jie Zhiwei, Wu Yizheng, Chen Junxin, Chen Zizheng, Fang Xiangqian, Shen Shuying |
热门标签：SV40转染人成骨细胞hFOB1.19,SV40转染人成骨细胞,SV40
